In particular, melanoma cells expressing high levels of bcl-2 displayed enhanced activation of the IL-1β/COX-2 axis, which paralleled an increased gene expression and secretion of IL-8, IL-17 and CCL2. This evidence concerns the gene PTGS2 and melanoma.